Designing a Metabolic Protocol

A metabolic optimization protocol begins with assessing the severity of insulin resistance through bloodwork. Mild insulin resistance (fasting insulin 8-12, HOMA-IR 1.5-2.5) may respond to MOTS-c alone combined with lifestyle changes. Moderate insulin resistance (fasting insulin 12-20, HOMA-IR 2.5-4.0) typically benefits from the addition of a GLP-1 agonist at low-to-moderate doses. Severe insulin resistance (fasting insulin above 20, HOMA-IR above 4.0, or established type 2 diabetes) may warrant aggressive intervention with higher-dose GLP-1 agonists or dual/triple agonists under close medical supervision.

A sample moderate metabolic protocol might include: semaglutide 0.25mg weekly (titrating up over 8-12 weeks), MOTS-c 5mg twice weekly, AOD-9604 300mcg daily (fasted), and BPC-157 500mcg daily (for the anti-inflammatory component of metabolic dysfunction). This protocol addresses insulin resistance directly (semaglutide, MOTS-c), promotes fat oxidation (AOD-9604), and tackles the inflammatory component of metabolic syndrome (BPC-157). Recheck fasting insulin, HOMA-IR, lipids, and inflammatory markers every 8-12 weeks.

Common pitfalls in metabolic protocols include titrating GLP-1 agonists too quickly (always follow slow titration schedules), neglecting lean mass preservation (ensure adequate protein intake of 1g per pound of lean body mass and resistance training), relying on peptides while ignoring foundational lifestyle factors, and stopping the protocol too early. Metabolic restoration is not a 4-week project. Most practitioners recommend a minimum of 6-12 months of consistent intervention to achieve lasting metabolic flexibility, at which point peptide doses can be gradually reduced while monitoring biomarkers to ensure gains are maintained.